West Pharmaceutical Services, Inc. (WST)
NYSE:WST

West Pharmaceutical Services (WST) Stock Price & Analysis

525 Followers

WST Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$205.87 - $422.87
Previous Close$268.62
Volume117.29K
Average Volume (3M)684.14K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$729.00M
Total Debt (Recent Filing)$299.90M
Price to Earnings (P/E)32.4
Beta1.36
Next EarningsFeb 16, 2023
Dividend Yield0.74 (0.27%)
EPS (TTM)8.30
Shares Outstanding74,032,987
R-Squared0.46
Standard Deviation0.09
10 Day Avg. Volume625,687
30 Day Avg. Volume684,143
Price to Book (P/B)8.03
Price to Sales (P/S)8.82
Price to Cash Flow (P/CF)29.80
P/FCF Ratio71.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside2.59% Upside
Rating ConsensusModerate Buy
Alpha0.01
Number of Analyst Covering3


Financials

Annual

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

WST FAQ

What was West Pharmaceutical Services’s price range in the past 12 months?
West Pharmaceutical Services lowest stock price was $205.87 and its highest was $422.87 in the past 12 months.
    What is West Pharmaceutical Services’s market cap?
    Currently, no data Available
    When is West Pharmaceutical Services’s upcoming earnings report date?
    West Pharmaceutical Services’s upcoming earnings report date is Feb 16, 2023 which is in 17 days.
      How were West Pharmaceutical Services’s earnings last quarter?
      West Pharmaceutical Services released its earnings results on Oct 27, 2022. The company reported $2.03 earnings per share for the quarter, missing the consensus estimate of $2.12 by -$0.09.
        Is West Pharmaceutical Services overvalued?
        According to Wall Street analysts West Pharmaceutical Services’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does West Pharmaceutical Services pay dividends?
          West Pharmaceutical Services pays a Quarterly dividend of $0.19 which represents an annual dividend yield of 0.27%. See more information on West Pharmaceutical Services dividends here
            What is West Pharmaceutical Services’s EPS estimate?
            West Pharmaceutical Services’s EPS estimate is $1.38.
              How many shares outstanding does West Pharmaceutical Services have?
              West Pharmaceutical Services has 74,032,990 shares outstanding.
                What happened to West Pharmaceutical Services’s price movement after its last earnings report?
                West Pharmaceutical Services reported an EPS of $2.03 in its last earnings report, missing expectations of $2.12. Following the earnings report the stock price went down -13.039%.
                  Which hedge fund is a major shareholder of West Pharmaceutical Services?
                  Among the largest hedge funds holding West Pharmaceutical Services’s share is Fisher Asset Management LLC. It holds West Pharmaceutical Services’s shares valued at 40M.

                    ---

                    West Pharmaceutical Services Stock Smart Score

                    4
                    Neutral
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10

                    Technicals

                    SMA
                    Negative
                    20 days / 200 days
                    Momentum
                    -29.83%
                    12-Months-Change

                    Fundamentals

                    Return on Equity
                    26.99%
                    Trailing 12-Months
                    Asset Growth
                    5.54%
                    Trailing 12-Months
                    The West Pharmaceutical Services stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    West Pharmaceutical Services, Inc.

                    West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

                    ---

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    IQVIA Holdings
                    Illumina
                    Mettler-Toledo
                    Waters
                    PerkinElmer

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis